This is an early access version
,
Faculty of medicine, University of Banja Luka , Banja Luka , Bosnia and Herzegovina
University clinical center of the Republic of Srpska , Banja Luka , Bosnia and Herzegovina
,
Faculty of medicine, University of Banja Luka , Banja Luka , Bosnia and Herzegovina
University clinical center of the Republic of Srpska , Banja Luka , Bosnia and Herzegovina
,
Faculty of medicine, University of Banja Luka , Banja Luka , Bosnia and Herzegovina
PHI Hospital „Sveti Vračevi“ , Bijeljina , Bosnia and Herzegovina
Faculty of medicine, University of Banja Luka , Banja Luka , Bosnia and Herzegovina
Faculty of medicine, University of Novi Sad , Novi Sad , Serbia
Introduction. Benign pituitary tumors are a heterogeneous group of neoplasms with varying clinical presentations depending on their hormonal activity, size, and mass effects. These tumors can cause significant morbidity due to endocrine dysfunction and compression of adjacent structures. Understanding their clinical characteristics is essential for improving diagnostic accuracy, optimizing treatment strategies, and predicting complications. This study aimed to evaluate the clinical profiles of patients with benign pituitary tumors, focusing on demographic characteristics, hormonal activity, and tumor size.
Methods. This retrospective five-year study (2019–2023) conductedat the University Clinical Center of Republic of Srpska, Banja Luka included patients diagnosed with benign pituitary tumors who underwent clinical, biochemical, and radiological evaluations. Demographic data, hormonal profiles, and tumor dimensions assessed via MRI were analyzed. Tumors were classified as functioning or non-functioning based on hormonal secretion. Statistical analysis explored associations between clinical parameters and tumor characteristics.
Results. This study analyzed data from patients diagnosed with benign pituitary gland neoplasms. The mean patient age was 48.61 years (SD = 17.60), ranging from 20 to 85 years. Among 53 patients with available tumor functionality data, 79.2% had functional adenomas, with prolactinomas being the most common (64.1%). Macroadenomas were present in 58.0% of cases, and 22.4% of tumors were invasive. Surgery was performed in 21 patients, with 76.2% undergoing transsphenoidal surgery. Remission was achieved in 5.9%, and complete resection in 17.7%.
Conclusions. A comprehensive assessment of clinical features in benign pituitary tumors is essential for tailoring individualized treatment and improving patient outcomes.
Conceptualization, A.M., T.D. and T.P.P.; Data curation, A.M. and T.P.P.; Formal Analysis, A.M.; Investigation, A.M., T.D., M.B. and T.P.P.; Methodology, A.M., T.D. and T.P.P.; Software, A.M.; Supervision, A.M.; Writing – original draft, A.M. and T.P.P.; Writing – review & editing, A.M., T.D., M.B. and T.P.P.; Validation, M.B. and T.P.P.; Visualization, T.P.P. All authors have read and agreed to the published version of the manuscript.
The data that support the findings of this study are available from the corresponding author upon reasonable individual request.
None.
Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. 
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.